Associated Papers
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.
Adnan-Awad S et al.
Leukemia, 2021
33168949 (PubMed )
Supplement: 41375_2020_1082_MOESM4_ESM.xlsx › S1
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.
Sapienza MR et al.
Haematologica, 2019
30381297 (PubMed )
Supplement: 2018.202093.SAPIENZA_SUPPL.pdf
Select a paper to view details